Winton Capital »

Summit Therapeutics shares owned by Winton Capital

Quarter-by-quarter ownership of Summit Therapeutics (SMMT) shares owned by Winton Capital from 13F filings

Historical chart of Winton Capital investment in Summit Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Summit Therapeutics held by Winton Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Summit Therapeutics by Winton Capital

Quarter filed Position value Share count Share price at filing
2025-09-30 $1.3M 65k 20.66

More positions owned by Winton Capital

Berkshire Hathaway Inc Del Cl A (BRK.A)
Ishares Tr Iboxx Hi Yd Etf (HYG)
Ishares Bitcoin Trust Etf Shs Ben Int (IBIT)
Fidelity Wise Origin Bitcoin SHS (FBTC)
Ge Vernova (GEV)
Select Sector Spdr Tr Sbi Materials (XLB)
Devon Energy Corporation (DVN)
Interactive Brokers Group In Com Cl A (IBKR)
Meta Platforms Cl A (META)
Uber Technologies (UBER)
Fastenal Company (FAST)
Incyte Corporation (INCY)
Masco Corporation (MAS)
Five Below (FIVE)
Johnson Ctls Intl SHS (JCI)

View all positions for Winton Capital

Top funds holding Summit Therapeutics

Baker Bros. Advisors
Vanguard Group
FMR
BlackRock
State Street Corporation
Geode Capital Management
Susquehanna International
Pictet Asset Management Holding SA
Citadel Advisors
UBS Group
Apeiron Capital
Nomura Holdings
Standard Life Aberdeen
Squarepoint Ops
Sofinnova Ventures

View all funds holding Summit Therapeutics